{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T03:52:44Z","timestamp":1775620364839,"version":"3.50.1"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T00:00:00Z","timestamp":1506643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["VGH-106-D23-001-MY2-1"],"award-info":[{"award-number":["VGH-106-D23-001-MY2-1"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Yen Tjing Ling Medical Foundation (TW)","award":["CI-100-34"],"award-info":[{"award-number":["CI-100-34"]}]},{"name":"Ministry of Science and Technology, Taiwan (TW)","award":["105-2314-B-075-039-"],"award-info":[{"award-number":["105-2314-B-075-039-"]}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["104-2627-B-010-001-"],"award-info":[{"award-number":["104-2627-B-010-001-"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0185615","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T17:39:44Z","timestamp":1506706784000},"page":"e0185615","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["The frequency of cancer predisposition gene mutations in hereditary breast and ovarian cancer patients in Taiwan: From BRCA1\/2 to multi-gene panels"],"prefix":"10.1371","volume":"12","author":[{"given":"Pi-Lin","family":"Sung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Chang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ta-Chung","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Fang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Ming","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Tai Timothy","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Chong","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Hsi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Mu","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng-Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5947-7995","authenticated-orcid":true,"given":"Chi-Ying F.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,9,29]]},"reference":[{"issue":"9","key":"ref1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1470-2045(02)00846-X","article-title":"Part I: chemotherapy for epithelial ovarian cancer-treatment at first diagnosis","volume":"3","author":"M Harries","year":"2002","journal-title":"The Lancet Oncology"},{"issue":"1","key":"ref2","first-page":"7","article-title":"Cancer Statistics, 2017","volume":"67","author":"RL Siegel","year":"2017","journal-title":"CA: a cancer journal for clinicians"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jfma.2015.10.011","article-title":"Incidence and survival of adult cancer patients in Taiwan, 2002\u20132012","volume":"115","author":"CJ Chiang","year":"2016","journal-title":"Journal of the Formosan Medical Association = Taiwan yi zhi"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1023\/B:BREA.0000003871.38587.8b","article-title":"Familial breast cancer: scope for more susceptibility genes?","volume":"82","author":"K Hemminki","year":"2003","journal-title":"Breast cancer research and treatment"},{"issue":"3","key":"ref5","first-page":"486","article-title":"Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes?","volume":"60","author":"OM Serova","year":"1997","journal-title":"American journal of human genetics"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/AOG.0b013e3181a106d4","article-title":"ACOG practice bulletin No. 103: hereditary breast and ovarian cancer syndrome","volume":"113","year":"2009","journal-title":"Obstetrics and gynecology"},{"issue":"23","key":"ref7","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/jnci\/djj465","article-title":"Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada","volume":"98","author":"HA Risch","year":"2006","journal-title":"Journal of the National Cancer Institute"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ejhg.2008.212","article-title":"Breast cancer susceptibility: current knowledge and implications for genetic counselling","volume":"17","author":"T Ripperger","year":"2009","journal-title":"European journal of human genetics: EJHG"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"S Chen","year":"2007","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.7326\/0003-4819-143-5-200509060-00011","article-title":"Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement","volume":"143","year":"2005","journal-title":"Annals of internal medicine"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/M13-2747","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement","volume":"160","author":"VA Moyer","year":"2014","journal-title":"Annals of internal medicine"},{"issue":"51","key":"ref12","doi-asserted-by":"crossref","first-page":"85529","DOI":"10.18632\/oncotarget.13456","article-title":"Prevalence and clinical significance of BRCA1\/2 germline and somatic mutations in Taiwanese patients with ovarian cancer","volume":"7","author":"A Chao","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"ref13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/jjco\/hyd092","article-title":"BRCA1 mutations in Taiwanese with epithelial ovarian carcinoma and sporadic primary serous peritoneal carcinoma","volume":"30","author":"PH Wang","year":"2000","journal-title":"Japanese journal of clinical oncology"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/jhg.2011.142","article-title":"Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancer","volume":"57","author":"WH Kuo","year":"2012","journal-title":"Journal of human genetics"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"8310","DOI":"10.18632\/oncotarget.7027","article-title":"Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer","volume":"7","author":"PH Lin","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10549-009-0639-z","article-title":"High-throughput resequencing in the diagnosis of BRCA1\/2 mutations using oligonucleotide resequencing microarrays","volume":"122","author":"C Schroeder","year":"2010","journal-title":"Breast cancer research and treatment"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10689-014-9749-9","article-title":"Detection of inherited mutations for hereditary cancer using target enrichment and next generation sequencing","volume":"14","author":"Y Guan","year":"2015","journal-title":"Familial cancer"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ygyno.2015.01.537","article-title":"Hereditary predisposition to ovarian cancer, looking beyond BRCA1\/BRCA2","volume":"137","author":"LE Minion","year":"2015","journal-title":"Gynecologic oncology"},{"issue":"13","key":"ref19","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1200\/JCO.2015.65.0747","article-title":"Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer","volume":"34","author":"N Tung","year":"2016","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"28","key":"ref20","doi-asserted-by":"crossref","first-page":"12629","DOI":"10.1073\/pnas.1007983107","article-title":"Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing","volume":"107","author":"T Walsh","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref21","first-page":"162","article-title":"An analysis of the cancer statistics of the Cancer Institute Siriraj Hospital, 1969\u20131972","volume":"59","author":"P Nilprabhassorn","year":"1976","journal-title":"Journal of the Medical Association of Thailand = Chotmaihet thangphaet"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ijc.30428","article-title":"Gene panel sequencing in familial breast\/ovarian cancer patients identifies multiple novel mutations also in genes others than BRCA1\/2","volume":"140","author":"C Kraus","year":"2017","journal-title":"International journal of cancer"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamaoncol.2015.2690","article-title":"Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment","volume":"1","author":"A Desmond","year":"2015","journal-title":"JAMA oncology"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1245\/s10434-015-4754-2","article-title":"Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1\/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1\/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer","volume":"22","author":"NS Kapoor","year":"2015","journal-title":"Annals of surgical oncology"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/ejhg.2014.16","article-title":"Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes","volume":"22","author":"L Castera","year":"2014","journal-title":"European journal of human genetics: EJHG"},{"issue":"9","key":"ref26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/gm274","article-title":"Targeted next-generation sequencing for routine clinical screening of mutations","volume":"3","author":"JM Weaver","year":"2011","journal-title":"Genome medicine"},{"issue":"19","key":"ref27","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1200\/JCO.2013.53.6607","article-title":"Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment","volume":"32","author":"AW Kurian","year":"2014","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"ref28","article-title":"Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer","author":"G Tedaldi","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ygyno.2009.02.017","article-title":"Hereditary breast and ovarian cancer syndrome","volume":"113","year":"2009","journal-title":"Gynecologic oncology"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.gastro.2006.10.034","article-title":"Novel resequencing chip customized to diagnose mutations in patients with inherited syndromes of intrahepatic cholestasis","volume":"132","author":"C Liu","year":"2007","journal-title":"Gastroenterology"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/humu.23113","article-title":"BRCA Share: A Collection of Clinical BRCA Gene Variants","volume":"37","author":"C Beroud","year":"2016","journal-title":"Hum Mutat"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"S Richards","year":"2015","journal-title":"Genetics in medicine: official journal of the American College of Medical Genetics"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"IA Adzhubei","year":"2010","journal-title":"Nature methods"},{"issue":"7","key":"ref34","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nprot.2009.86","article-title":"Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm","volume":"4","author":"P Kumar","year":"2009","journal-title":"Nature protocols"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s004390050936","article-title":"Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan","volume":"104","author":"SS Li","year":"1999","journal-title":"Human genetics"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1023\/A:1021386026051","article-title":"Mutational screening of breast cancer susceptibility gene 1 from early onset, bi-lateral, and familial breast cancer patients in Taiwan","volume":"77","author":"ST Chen","year":"2003","journal-title":"Breast cancer research and treatment"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1200\/JCO.2002.20.4.994","article-title":"BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic","volume":"20","author":"HA Shih","year":"2002","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"7006","key":"ref38","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nature02878","article-title":"Genetic evidence supports demic diffusion of Han culture","volume":"431","author":"B Wen","year":"2004","journal-title":"Nature"},{"issue":"8","key":"ref39","doi-asserted-by":"crossref","first-page":"9600","DOI":"10.18632\/oncotarget.7144","article-title":"Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients","volume":"7","author":"YC Kim","year":"2016","journal-title":"Oncotarget"},{"issue":"11","key":"ref40","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1158\/1055-9965.EPI-07-0403","article-title":"BRCA1 and BRCA2 mutations in an Asian clinic-based population detected using a comprehensive strategy","volume":"16","author":"P Ang","year":"2007","journal-title":"Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"issue":"5","key":"ref41","first-page":"1013","article-title":"Population genetics of BRCA1 and BRCA2","volume":"60","author":"CI Szabo","year":"1997","journal-title":"American journal of human genetics"},{"issue":"11","key":"ref42","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/gim.2014.40","article-title":"Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients","volume":"16","author":"H LaDuca","year":"2014","journal-title":"Genetics in medicine: official journal of the American College of Medical Genetics"},{"issue":"13","key":"ref43","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.7314\/APJCP.2015.16.13.5211","article-title":"Targeted Resequencing of 30 Genes Improves the Detection of Deleterious Mutations in South Indian Women with Breast and\/or Ovarian Cancers","volume":"16","author":"T Rajkumar","year":"2015","journal-title":"Asian Pacific journal of cancer prevention: APJCP"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"15003","DOI":"10.1038\/npjgenmed.2015.3","article-title":"Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from Singapore","volume":"1","author":"ESY Wong","year":"2016","journal-title":"NPJ Genom Med"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/cge.12735","article-title":"Identification of germline alterations in breast cancer predisposition genes among Malaysian breast cancer patients using panel testing","volume":"90","author":"PS Ng","year":"2016","journal-title":"Clinical genetics"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/cncr.26191","article-title":"Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer","volume":"118","author":"ZK Stadler","year":"2012","journal-title":"Cancer"},{"issue":"5","key":"ref47","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/ijc.20162","article-title":"A high proportion of founder BRCA1 mutations in Polish breast cancer families","volume":"110","author":"B Gorski","year":"2004","journal-title":"International journal of cancer"},{"issue":"9","key":"ref48","doi-asserted-by":"crossref","first-page":"e43994","DOI":"10.1371\/journal.pone.0043994","article-title":"Identification of BRCA1\/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis","volume":"7","author":"A Kwong","year":"2012","journal-title":"PloS one"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10549-015-3377-4","article-title":"The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study","volume":"151","author":"E Kang","year":"2015","journal-title":"Breast cancer research and treatment"},{"issue":"7","key":"ref50","doi-asserted-by":"crossref","first-page":"e0134408","DOI":"10.1371\/journal.pone.0134408","article-title":"Predictive factors for BRCA1 and BRCA2 genetic testing in an Asian clinic-based population","volume":"10","author":"ES Wong","year":"2015","journal-title":"PloS one"},{"issue":"12","key":"ref51","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/s12094-015-1435-3","article-title":"SEOM clinical guidelines in hereditary breast and ovarian cancer","volume":"17","author":"G Llort","year":"2015","journal-title":"Clin Transl Oncol"},{"issue":"2","key":"ref52","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: recommendation statement","volume":"91","year":"2015","journal-title":"American family physician"},{"issue":"3","key":"ref53","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10689-012-9519-5","article-title":"Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases","volume":"11","author":"I Brozek","year":"2012","journal-title":"Familial cancer"},{"key":"ref54","article-title":"Moving towards population-based genetic risk prediction for ovarian cancer","author":"B Rahman","year":"2017","journal-title":"BJOG"},{"issue":"9","key":"ref55","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nrclinonc.2010.116","article-title":"Making the best of PARP inhibitors in ovarian cancer","volume":"7","author":"S Banerjee","year":"2010","journal-title":"Nature reviews Clinical oncology"},{"issue":"7","key":"ref56","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0968-0004(99)01413-9","article-title":"DNA recombination: the replication connection","volume":"24","author":"JE Haber","year":"1999","journal-title":"Trends in biochemical sciences"},{"issue":"2","key":"ref57","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1097-2765(01)00174-5","article-title":"BRCA2 is required for homology-directed repair of chromosomal breaks","volume":"7","author":"ME Moynahan","year":"2001","journal-title":"Molecular cell"},{"issue":"4","key":"ref58","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S1097-2765(00)80202-6","article-title":"Brca1 controls homology-directed DNA repair","volume":"4","author":"ME Moynahan","year":"1999","journal-title":"Molecular cell"},{"issue":"4","key":"ref59","first-page":"e158","article-title":"Correction to Lancet Oncol 2014; 15: 856. Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial","volume":"16","author":"J Ledermann","year":"2015","journal-title":"The Lancet Oncology"},{"issue":"22","key":"ref60","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1056\/NEJMoa1611310","article-title":"Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer","volume":"375","author":"MR Mirza","year":"2016","journal-title":"The New England journal of medicine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0185615","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T08:48:30Z","timestamp":1589791710000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0185615"}},"subtitle":[],"editor":[{"given":"Amanda Ewart","family":"Toland","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,9,29]]},"references-count":60,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,9,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0185615","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,29]]}}}